Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy. (Q54422031)
scientific article
Language:
Current Data About Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
(P31) (Q13442814)
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P304) 1468-1469
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P407) (Q1860)

(P433) 22
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P478) 318
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P577) Wednesday, June 1, 1988
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P921) (Q180983)
(P887)

(Q954625)
(P887)

(P1433) (Q582728)
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P1476) "Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy." (language: en)
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

(P2093) Layton DM
(P1545) 1
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

Mufti GJ
(P1545) 2
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

Lyons J
(P1545) 3
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

Janssen JW
(P1545) 4
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

Bartram CR
(P1545) 5
(P248)
(P698) 3285212
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3285212

other details
description scientific article

External Links
(P356) 10.1056/NEJM198806023182215
(P698) 3285212